Your browser doesn't support javascript.
loading
Letter: Early real-world evidence from the United Arab Emirates of the persistence, effectiveness and safety of risankizumab for the treatment of Crohn's disease.
Alahmad, Maryam; Quraishi, Mohammed Nabil; Khan, Shaima Wasim; Omar, Nadeen Mamon; Malik, Talha A.
Affiliation
  • Alahmad M; Department of Gastroenterology, Sheikh Shakhbout Medical City, Abu Dhabi, United Arab Emirates.
  • Quraishi MN; Department of Gastroenterology, Sheikh Shakhbout Medical City, Abu Dhabi, United Arab Emirates.
  • Khan SW; Department of Gastroenterology, Sheikh Shakhbout Medical City, Abu Dhabi, United Arab Emirates.
  • Omar NM; Department of Gastroenterology, Sheikh Shakhbout Medical City, Abu Dhabi, United Arab Emirates.
  • Malik TA; Department of Gastroenterology, Sheikh Shakhbout Medical City, Abu Dhabi, United Arab Emirates.
Aliment Pharmacol Ther ; 60(1): 101-102, 2024 07.
Article in En | MEDLINE | ID: mdl-38779929
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Crohn Disease / Antibodies, Monoclonal Limits: Female / Humans Country/Region as subject: Asia Language: En Journal: Aliment Pharmacol Ther Journal subject: FARMACOLOGIA / GASTROENTEROLOGIA / TERAPIA POR MEDICAMENTOS Year: 2024 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Crohn Disease / Antibodies, Monoclonal Limits: Female / Humans Country/Region as subject: Asia Language: En Journal: Aliment Pharmacol Ther Journal subject: FARMACOLOGIA / GASTROENTEROLOGIA / TERAPIA POR MEDICAMENTOS Year: 2024 Document type: Article Affiliation country: Country of publication: